In this video, Gautam Dantas, PhD, discusses how the results of his study showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease.
In this video, Madhav Thambisetty, MD, discusses a new treatment for patients with Alzheimer disease, lecanemab, recently approved by the FDA, including the presumed mechanism of action, benefits, risks,...
In this video, Gillian T. Coughlan, MS, PhD discussed her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide a preview of their session, "Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem ” at our Practical Updates...
In this podcast, Thomas Holland, MD, from Rush University, answers our questions about his team's latest research on the effect of flavonols on the risk for Alzheimer dementia, as well as his other research...
New research investigated the nervous system cell types in which putative migraine-associated genes are expressed. Lead author William Renthal, MD, PhD, answers our questions about this research.
In this video, Barak Gaster, MD discusses identifying dementia and managing care in the primary care setting, a topic he is presenting at our Practical Updates in Primary Care 2021 Virtual Series on May...
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
A new study suggests that late-onset unprovoked seizures of unknown etiology may be associated with a doubled risk of developing dementia among older veterans. Neurology Consultant spoke with corresponding...
